, Yoon Ha Hwang
Department of Pediatrics, Busan St. Mary's Medical Center, Busan, Korea
© 2025 Kosin University College of Medicine.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Funding
None.
Author contributions
Conceptualization: JKK, YHH. Data curation: JKK. Investigation: JKK. Methodology: JKK, YHH. Project administration: JKK. Resources: JKK, YHH. Supervision: YHH. Visualization: JKK. Writing-original draft: JKK. Writing-review & editing: JKK, YHH. All authors read and approved the final manuscript.
| Spirometry | Measurement | Reference | Predicted value (%) | |||
|---|---|---|---|---|---|---|
| 2023-04-08 | 2023-08-02 | 2023-04-08 | 2023-08-02 | 2023-04-08 | 2023-08-02 | |
| FVC (L) | 1.23 | 2.12 | 2.99 | 3.08 | 41.1 | 68.8 |
| FEV1 (L) | 1.00 | 1.44 | 2.84 | 2.93 | 35.2 | 49.1 |
| FEV1/FVC (%) | 81.3 | 67.9 | 86.0 | 86.0 | ||
| FEF25%–75% (L/s) | 0.96 | 1.18 | 3.22 | 3.36 | 30 | 35 |
| Medication | Manufacturer | Dosage |
|---|---|---|
| Flixotide Junior Evohaler | GlaxoSmithKline | 50 μg: 120 doses/bottle |
| Ventolin Nebule | GlaxoSmithKline | 2.5 mg/2.5 mL: each |
| Pulmicort Respule (micronized) | AstraZeneca | 0.5 mg: 2 mL/bottle |
| Solondo Tab. | Yuhan Corp. | 5 mg: tablet |
| Ventolin Evohaler | GlaxoSmithKline | 0.1 mg: 200 doses/bottle |
| Singulair Tab. | Organon Canada Inc. | 10 mg: tablet |
| Spiriva Cap. | Boehringer-Ingelheim | 18 μg: 30 capsules/box |
| Symbicort Turbuhaler | AstraZeneca | 320/9 μg: 60 doses/bottle |
| Variable | Reference range | 2022-12-27 | 2023-04-09 |
|---|---|---|---|
| WBC differential count | |||
| Eosinophil (%) | 0–4 | 1.3 | 1.2 |
| IgE, total (IU/mL) | 0–199.9 | 78.6 | 50.2 |
| Hemoglobin (g/dL) | 12–17 | 14.7 | 15.6 |
| O2 saturation (%) | 95 | 98 | |
| Unicap Profile 10 (inhalant, KUA/L) | |||
| Allergen-specific IgE, T3 (birch) | 0–0.35 | 0 (0.01) | |
| Allergen-specific IgE, W22 (Japanese hop) | 0–0.35 | 0 (0.00) | |
| Allergen-specific IgE, W1 (common ragweed) | 0–0.35 | 0 (0.01) | |
| Allergen-specific IgE, T7 (oak) | 0–0.35 | 0 (0.03) | |
| Allergen-specific IgE, D1 (Dermatophagoides pteronyssinus) | 0–0.35 | 0 (0.02) | |
| Allergen-specific IgE, D2 (Dermatophagoides farinae) | 0–0.35 | 0 (0.01) | |
| Allergen-specific IgE, M6 (Alternaria tenuis) | 0–0.35 | 0 (0.03) | |
| Allergen-specific IgE, T2 (gray alder) | 0–0.35 | 0 (0.01) | |
| Allergen-specific IgE, E1 (cat) | 0–0.35 | 0 (0.00) | |
| Allergen-specific IgE, E5 (dog) | 0–0.35 | 0 (0.01) |
| Variable | 2022-12-04 |
|---|---|
| VBGA | |
| Blood pH | 7.34 |
| pCO2 (mmHg) | 58 |
| pO2 (mmHg) | 16 |
| HCO3- (mmol/L) | 31.3 |
| Total CO2 (%) | 33.1 |
| Base excess (mmol/L) | 3.7 |
| O2 content (mL/dL) | 2.7 |
| O2 saturation (%) | 12.1 |
| ABGA | |
| Hematocrit (%) | 47 |
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; FEF25%–75%, forced mid-expiratory flow 25%–75%.
Values in parentheses indicate actual measured values; all within negative range. WBC, white blood cell; IgE, immunoglobulin E.
VBGA, venous blood gas analysis; pCO2, partial pressure of CO2; pO2, partial pressure of O2; ABGA, arterial blood gas analysis.